FRM
MRNA icon

Fox Run Management’s Moderna MRNA Stock Holding History

Fox Run Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-20,813
Closed -$574K – 1120
2025
Q2 		$574K Buy
20,813
+8,844
+74% +$233K 0.1% 404
2025
Q1 		$339K Buy
+11,969
New +$425K 0.05% 632
2024
Q4 		– Sell
-3,390
Closed -$227K – 1063
2024
Q3 		$227K Buy
+3,390
New +$311K 0.05% 640
2023
Q4 		– Sell
-2,316
Closed -$239K – 906
2023
Q3 		$239K Buy
2,316
+89
+4% +$9.93K 0.07% 515
2023
Q2 		$271K Buy
+2,227
New +$297K 0.08% 483

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Fox Run Management's MRNA Position: Q3 2025 in Review

Fox Run Management sold out of Moderna (MRNA) in Q3 2025, closing a stake of 20,813 shares — an estimated $574K sold.

Fox Run Management first reported a position in MRNA in Q2 2023 and held it in 5 quarters. The position peaked at $574K in Q2 2025. 643 funds tracked by Wall St. Rank hold MRNA as of Q3 2025.

  • Fox Run Management reported no remaining Moderna position as of Q3 2025 after selling out during the quarter.
  • Fox Run Management sold 20,813 Moderna shares in Q3 2025, an estimated $574K.
  • Fox Run Management first reported a position in Moderna in Q2 2023 and held it in 5 quarters.
  • Fox Run Management's Moderna position peaked at $574K in Q2 2025.
  • 643 funds tracked by Wall St. Rank held Moderna as of Q3 2025.

Based on Fox Run Management's 13F filing for Q3 2025, filed 12 Nov 2025.